WEEKLY NEWSLETTER

Health's Top Stories
Get a weekly look at the most popular stories on Health.com.

Multiple Sclerosis (MS)


content provided by Healthwise

References

Citations

  1. Ropper AH, Brown RH (2005). Multiple sclerosis and allied demyelinative diseases. In Adams and Victor's Principles of Neurology, 8th ed., pp. 771–796. New York: McGraw-Hill.

  2. Bennett KA (2005). Pregnancy and multiple sclerosis. Clinical Obstetrics and Gynecology, 48(1): 38–47.

  3. Giesser B (2003). Reproductive Issues in Persons With Multiple Sclerosis. Clinical Bulletin: Information for Health Professionals. New York: National Multiple Sclerosis Society.

  4. Frohman EM (2003). Multiple sclerosis. Medical Clinics of North America, 87(4): 867–897.

  5. McDonald WI, et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50(1): 121–127.

  6. Polman CH, et al. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Annals of Neurology, 58(6): 840–846.

  7. Sadiq SA (2005). Multiple sclerosis. In LP Rowland, ed., Merritt's Neurology, 11th ed., pp. 941–963. Philadelphia: Lippincott Williams and Wilkins.

  8. Tintoré M (2003). New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode. Neurology, 60(1): 27–30.

  9. National Clinical Advisory Board of the National Multiple Sclerosis Society (2007). Disease Management Consensus Statement. New York: National Multiple Sclerosis Society. Available online: http://www.nationalmssociety.org/site/PageServer?pagename=HOM_PRO_expert_opinion_papers.

  10. Lindsey JW, Wolinsky JS (2005). Demyelinating diseases. In DC Dale, DD Federman, eds., ACP Medicine, section 11, chap. 9. New York: WebMD.

  11. Fassas A, et al., (2002). Hematopoietic stem cell transplantation for multiple sclerosis: A retrospective study. Journal of Neurology, 249(8): 1088–1097.

Other Works Consulted

  • Yousry TA, et al. (2006). Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. New England Journal of Medicine, 354(9): 924–933.



Last Updated: February 28, 2008
Author:
Monica Rhodes
Medical Review:
Anne C. Poinier, MD - Internal Medicine

Colin Chalk, MD, CM, FRCPC - Neurology


© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.



This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.